Early diagnosis and standardized treatment are critical to improve the prognosis of patients with Takayasu’s arteritis
Authors:
Open Access
- 1 March 2024
- journal article
- editorial
- Published by Walter de Gruyter GmbH in Rheumatology and Immunology Research
- Vol. 5 (1) , 1-4
Abstract
Article Early diagnosis and standardized treatment are critical to improve the prognosis of patients with Takayasu’s arteritis was published on March 1, 2024 in the journal Rheumatology and Immunology Research (volume 5, issue 1).Keywords
This publication has 8 references indexed in Scilit:
- [Chinese guideline for the diagnosis and treatment of Takayasu's arteritis(2023)].2024
- Clinical characteristics of adult patients with systemic vasculitis: Data of 1348 patients from a single centerRheumatology and Immunology Research, 2021
- Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomised, double-blind, placebo-controlled, phase 3 trial in Japan (the TAKT study)Annals of the Rheumatic Diseases, 2018
- A Randomized, Double‐Blind Trial of Abatacept (CTLA‐4Ig) for the Treatment of Giant Cell ArteritisArthritis & Rheumatology, 2017
- Brief Report: Takayasu Arteritis and Ulcerative Colitis: High Rate of Co‐Occurrence and Genetic OverlapArthritis & Rheumatology, 2015
- Diagnosis and Assessment of Disease Activity in Takayasu Arteritis: A Childhood Case Illustrating the ChallengeCase Reports in Rheumatology, 2014
- Takayasu arteritis—advances in diagnosis and managementNature Reviews Rheumatology, 2010
- Long-term outcome for 120 Japanese patients with Takayasu's disease. Clinical and statistical analyses of related prognostic factors.Circulation, 1994